iX Biopharma Ltd announced on Jun, 8 2026 that it has issued 512,400 new ordinary shares following the exercise of warrants at an exercise price of 0.06 million Singapore dollars per share.

The company’s total share count has increased from 1,057,006,585 to 1,057,518,985. The new shares will rank pari passu with existing shares and are expected to begin trading on the Singapore Exchange on Jun, 10 2026.

To date, 21,341,921 warrants, representing 37.11% of the warrants previously issued, have been exercised. A total of 36,167,558 warrants remain outstanding, each with an exercise price of 0.06 million Singapore dollars and an expiry date of Jul, 18 2026.